# S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/s2r1-genotoxicity-testing-and-data-interpretation-for-pharmaceuticals-intended-for-human-use/bdcb4e58-2f39-40e7-90c5-9f222d9203c1

> FDA guidance document: S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. Issue date: June 07, 2012. Get complete insights and analysis.

---

## Details

- Title: S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2012-06-07
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0178">FDA-2008-D-0178</a>

## Related Documents

- [S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals](https://www.keypedia.com/guidances/guidance-document/s6-r1-addendum-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/de0d3a32-bb96-4225-a321-61404f42a946)
- [S9 Nonclinical Evaluation for Anticancer Pharmaceuticals](https://www.keypedia.com/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals/0d1f71ec-dd43-4c57-befe-2d7eb7e145f2)
- [Q11 Development and Manufacture of Drug Substances](https://www.keypedia.com/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411)